Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.95M Buy
43,502
+2,724
+7% +$249K 1.13% 29
2026
Q1
$4.19M Buy
40,778
+4,277
+12% +$483K 1.09% 34
2025
Q4
$4.57M Buy
36,501
+614
+2% +$78.2K 1.14% 28
2025
Q3
$4.81M Sell
35,887
-857
-2% -$113K 1.17% 29
2025
Q2
$5M Sell
36,744
-1,648
-4% -$217K 1.24% 25
2025
Q1
$5.09M Buy
+38,392
New +$4.89M 1.36% 24

Other funds holding ABT

Davis Rea's ABT Position: Q2 2026 in Review

Davis Rea increased its Abbott (ABT) stake by 6.7% in Q2 2026, buying an estimated $249K and bringing the position to 43,502 shares worth $3.95M. The position accounts for 1.13% of the portfolio, ranked #29.

Davis Rea first reported a position in ABT in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.09M in Q1 2025. 2,968 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Davis Rea held 43,502 shares of Abbott worth $3.95M as of Q2 2026.
  • Davis Rea bought 2,724 Abbott shares in Q2 2026, an estimated $249K.
  • Abbott made up 1.13% of Davis Rea's portfolio in Q2 2026, its #29 holding.
  • Davis Rea first reported a position in Abbott in Q1 2025 and has held it in 6 quarters since.
  • Davis Rea's Abbott position peaked at $5.09M in Q1 2025.
  • 2,968 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Davis Rea's 13F filing for Q2 2026, filed 4 Aug 2026.